| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13137* | 2021 |
| Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ... New England journal of medicine 384 (5), 403-416, 2021 | 9936 | 2021 |
| National Institutes of Health consensus development conference statement: management of hepatitis C National Institutes of Health Hepatology 36 (1), 5, 2002 | 1212* | 2002 |
| Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant RS Sperling, DE Shapiro, RW Coombs, JA Todd, SA Herman, ... New England Journal of Medicine 335 (22), 1621-1629, 1996 | 1076 | 1996 |
| 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus H Masur, JE Kaplan, KK Holmes, BL Alston, N Ampel, JR Anderson, ... Clinical Infectious Diseases 30, S29-S65, 2000 | 963* | 2000 |
| Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study WT Shearer, HM Rosenblatt, RS Gelman, R Oyomopito, S Plaeger, ... Journal of Allergy and Clinical Immunology 112 (5), 973-980, 2003 | 910 | 2003 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 903 | 2022 |
| Guidelines for preventing opportunistic infections among HIV-infected persons—2002: recommendations of the US Public Health Service and the Infectious Diseases Society of America PH Masur, JE Kaplan, KK Holmes Annals of internal medicine 137 (5_Part_2), 435-478, 2002 | 847 | 2002 |
| Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections: Studies with … I Grant, JH Atkinson, JR HESSELINK, CJ KENNEDY, DD RICHMAN, ... Annals of internal medicine 107 (6), 828-836, 1987 | 838 | 1987 |
| The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind, placebo … MA Fischl, DD Richman, N Hansen, AC Collier, JT Carey, MF Para, ... Annals of internal medicine 112 (10), 727-737, 1990 | 813 | 1990 |
| Identification of a candidate therapeutic autophagy-inducing peptide S Shoji-Kawata, R Sumpter, M Leveno, GR Campbell, Z Zou, L Kinch, ... Nature 494 (7436), 201-206, 2013 | 803 | 2013 |
| Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy DD Richman, D Havlir, J Corbeil, D Looney, C Ignacio, SA Spector, ... Journal of virology 68 (3), 1660-1666, 1994 | 758 | 1994 |
| A health status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection AW Wu, HR Rubin, WC Mathews, JE Ware Jr, LT Brysk, WD Hardy, ... Medical care 29 (8), 786-798, 1991 | 753 | 1991 |
| Prevalence of psychiatric disorders among men infected with human immunodeficiency virus: a controlled study JH Atkinson, I Grant, CJ Kennedy, DD Richman, SA Spector, ... Archives of General Psychiatry 45 (9), 859-864, 1988 | 626 | 1988 |
| Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents Panel on Clinical Practices for Treatment of HIV Infection African journal of medical practice 5 (2), 79-104, 1998 | 519* | 1998 |
| Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome RJ Ellis, K Hsia, SA Spector, JA Nelson, RK Heaton, MR Wallace, ... Annals of neurology 42 (5), 679-688, 1997 | 410 | 1997 |
| A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection WG Powderly, DM Finkelstein, J Feinberg, P Frame, W He, ... New England Journal of Medicine 332 (11), 700-705, 1995 | 396 | 1995 |
| Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study RJ Whitley, G Cloud, W Gruber, GA Storch, GJ Demmler, RF Jacobs, ... Journal of Infectious Diseases 175 (5), 1080-1086, 1997 | 388 | 1997 |
| High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection D Havlir, SH Cheeseman, M Mclaughlin, R Murphy, A Erice, SA Spector, ... Journal of Infectious Diseases 171 (3), 537-545, 1995 | 385 | 1995 |
| A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection SA Bozzette, DM Finkelstein, SA Spector, P Frame, WG Powderly, W He, ... New England Journal of Medicine 332 (11), 693-699, 1995 | 378 | 1995 |
